Energy News / Shareholders Foundation, Inc.

NASDAQ:AMRN Shareholder Notice: Lawsuit Alleges Misleading Statements by Amarin Corporation Plc

Via: ReleaseWire

Updated 11:30 AM CDT, Mon, March 11,2019

A lawsuit was filed on behalf of investors in Amarin Corporation plc (NASDAQ: AMRN) shares over alleged securities laws violations.

San Diego, CA -- (SBWIRE) -- 03/11/2019 -- An investor, who purchased shares of Amarin Corporation plc (NASDAQ: AMRN), filed a lawsuit over alleged Securities Laws violations by Amarin Corporation plc in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Amarin Corporation plc (NASDAQ: AMRN) have certain options and for certain investors are short and strict deadlines running. Deadline: April 23, 2019. NASDAQ: AMRN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Ireland based Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. On November 12, 2018, an article was published, entitled "Amarin's REDUCE-IT Trial: Something Fishy?" The article addressed Amarin's "recent revelations of positive topline results" from its REDUCE-IT trial for Vascepa, its sole product. Specifically, the article raised the possibility that "the placebo group received an active agent that in effect was an anti-statin", and that the REDUCE-IT trial results may have consequently exaggerated the efficacy of Vascepa.

The plaintiff claims that between September 24, 2018 and November 8, 2018, the defendants made false and misleading statements or failed to disclose that the top-line results Amarin touted about its REDUCE-IT trial for Vascepa were not as positive as the company represented, thatthe placebo given to patients in the control arm of REDUCE-IT may have increased the incidence of cardiovascular events in those patients, and that as a result, Amarin's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Amarin Corporation plc (NASDAQ: AMRN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqamrn-shareholder-notice-lawsuit-alleges-misleading-statements-by-amarin-corporation-plc-1167719.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com